Medical/Pharmaceuticals
Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA
INCHEON, South Korea, Sept. 22, 2021 /PRNewswire/ -- Samsung Biologics, a global contract development and manufacturing organization (CDMO), introduced its proprietary technology platform, S-CellerateTM, at the BioProcess International Conference (BPI 2021) to offer clients an integrated and seam...
2021-09-22 18:00
2312
The World Federation of Hemophilia (WFH), in collaboration with the New York University (NYU) Wagner Graduate School of Public Service, launches a new academic training program for bleeding disorder advocates: The PACT Advocacy Academy
MONTREAL, Sept. 22, 2021 /PRNewswire/ -- Taught exclusively online by renowned experts in the field of advocacy and bleeding disorders, this unique 8-month course will equip WFH national member organization (NMO) advocates with the knowledge and tools necessary to advocate for increased access to...
2021-09-22 17:00
2654
The International Standard Proposed by Experts from BMC Medical in Terms of High-flow Respiratory Therapy Equipment Officially Released
BEIJING, Sept. 22, 2021 /PRNewswire/ -- The international standard for high-flow respiratory therapy equipment (standard number: ISO 80601-2-90:2021) proposed by BMC Medical standardization technical experts has been formally released recently on the official websites of the International Organiz...
2021-09-22 15:00
3645
Asieris Appoints Dr. Alice Chen as Vice President, Discovery Biology and Head of Translational Research
SHANGHAI, Sept. 22, 2021 /PRNewswire/ -- Asieris Pharmaceuticals announced the appointment of Dr.Alice Chen as Vice President, Discovery Biology and Head of Translational Research with effect fromSeptember 20, 2021. She will report to Dr.Kevin Pan, Founder and CEO of Asieris. Alice has over 20 ...
2021-09-22 14:45
1560
New Therapy to Treat Advanced Small Cell Lung Cancer ZEPZELCA® (lurbinectedin) Approved in Singapore
Highlights: * ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20 years * ZEPZELCA provisional approval represents an important advance for adult patients whose metastatic SCLC has progressed on or after platinum-...
2021-09-22 14:30
2432
Urotronic Inc., Announces Completion of the First Optilume(R) Procedure in Asia
The Optilume® Drug Coated Balloon is a novel, minimally invasive technology for the treatment of urethral stricture. MINNEAPOLIS, Sept. 22, 2021 /PRNewswire/ -- Urotronic, Inc., a Minnesota based medical device company, today announced the first Optilume® Drug Coated Balloon procedure for the tr...
2021-09-22 10:21
3049
Dr. Ivan Puah Sees An Increasing Number Of Patients Seeking Liposuction Correction Surgeries In Singapore
SINGAPORE, Sept. 22, 2021 /PRNewswire/ -- Dr Ivan Puah, an MOH-accredited liposuction doctor and Medical Director of Amaris B. Clinic, has seen a surge of patients seeking correction on their previously done liposuction from other cosmetic surgery clinics. Liposuction is a surgical techniqu...
2021-09-22 10:10
2858
1cm "Lasso" Technique for Ankle Ligament Reconstruction, Co-developed by Dr James Wee from Oxford Orthopaedics
SINGAPORE, Sept. 22, 2021 /PRNewswire/ -- Ankle Ligament Reconstruction Ankle Ligament Reconstruction is the surgical treatment of ankle injuries or damaged ankle ligaments to restore stability and function. Ankle sprains make up about half of all sports-related injuries and also commonly occurs...
2021-09-22 10:00
2924
LSO Medical Announces CE Approval of Next-Gen LUMESEAL Laser for Treatment of Varicose Vein.
LILLE, France, Sept. 22, 2021 /PRNewswire/ -- LSO MEDICAL SAS, international leader in vascular laser therapies, announced today the CE Approval of its newest generation EVLT SnakeBack® assisted system, the LUMESEAL® laser platform. Designed to enhance ease-of-use and to provide greater precision...
2021-09-22 03:04
2725
Koji Tanabe, CEO of I Peace, Inc. honored by World Biz Magazine with "Top 100 Innovation CEO" Award
PALO ALTO, Calif., Sept. 21, 2021 /PRNewswire/ -- Koji Tanabe, Founder and CEO
of I Peace, Inc. (https://www.ipeace.com
2021-09-22 02:00
2047
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
RALEIGH, N.C., Sept. 21, 2021 /PRNewswire/ -- Mayne Pharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved LEXETTE® (halobetasol propionate) foam, 0.05% for use in adolescents. LEXETTE, a super potent topical corticosteroid, is now approved for the treatment ...
2021-09-21 22:00
5191
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
The solution offers superior ease of formulation, potential application versatility, and more comprehensive immune support compared to probiotics and other immune health ingredients SANTA CLARA, Calif., Sept. 21, 2021 /PRNewswire/ -- Based on its recent analysis of the North American immune hea...
2021-09-21 20:00
1941
Farrer Park Hospital Enhances Dementia services to Better Guide Management and Care Plan for People with Dementia
SINGAPORE, Sept. 21, 2021 /PRNewswire/ -- Farrer Park Hospital
2021-09-21 08:15
3364
Fullerton Health launches DigiHealth Kiosk to improve accessibility and affordability of healthcare for Migrant Workers
SINGAPORE, Sept. 21, 2021 /PRNewswire/ -- The COVID 19 Pandemic has shown the
importance of primary care for all segments of society, including Migrants
Workers.
2021-09-21 07:00
3673
Novavax to Participate in Fireside Chat at Devex @ UNGA 76
GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing and commercializing next-generation vaccines for serious infectious diseases, today announced thatJohn J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Busin...
2021-09-21 04:46
8540
RhoVac announces the completion of patient recruitment for the BRaVac clinical phase IIb study of RV001 in prostate cancer
STOCKHOLM, Sept. 21, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today onSep 20th , 2021, that its clinical phase IIb study of lead drug candidate RV001 in prostate cancer, BRaVac, is deemed fully recruited and that no additional patients will be ...
2021-09-21 04:06
2020
Alterity Announces Presentation of Biomarker Data at the International Parkinson and Movement Disorder Society Congress 2021
MELBOURNE, Australia and SAN FRANCISCO, Sept. 20, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced that data was present...
2021-09-20 22:51
7751
ZEISS Introduces a Series of Major Innovations and Industry-First Software Applications as Part of the ZEISS Medical Ecosystem
A fully connected and integrated approach keeps ZEISS at the forefront of ophthalmology with new data management innovations across devices, workflow solutions and software applications. JENA, Germany and DUBLIN, Calif., Sept. 20, 2021 /PRNewswire/ -- At ZEISS Innovation Week,September 21- 23, 2...
2021-09-20 22:00
3293
PharmAbcine to Participate in BIO-Europe 2021
DAEJEON, South Korea, Sept. 20, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next generation antibody therapeutics, announced today that the Company will virtually participate in the 27th annual BIO-Europe which will tak...
2021-09-20 20:00
2003
CStone presents clinical data from the China registrational bridging study on ivosidenib in patients with relapsed/refractory acute myeloid leukemia (R/R AML) with a susceptible IDH1 mutation at the 2021 ESMO Congress
* The data showed that ivosidenib demonstrated clinical efficacy in the treatment of Chinese adults with R/R AML with a susceptible IDH1 mutation. And ivosidenib was well tolerated and had a manageable safety profile * In August 2021, the National Medical Products Administration (NMPA) of Chin...
2021-09-20 20:00
5461
Week's Top Stories
Most Reposted
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
[Picked up by 309 media titles]
2026-07-30 10:45
J.P. Morgan Private Bank Earns Record 10 Accolades at The Asset Triple A Private Capital Awards 2026
[Picked up by 294 media titles]
2026-07-30 15:00KC Global Media announces new travel series "AXN Ultimate Challenge: Sarawak"
[Picked up by 292 media titles]
2026-07-30 09:12
Articura Launches a New Chapter for Sovereign Healthcare AI in Indonesia
[Picked up by 291 media titles]
2026-07-27 19:02
ADA acquires Algonomy, strengthening its intelligent growth platform for a fully agentic experience
[Picked up by 290 media titles]
2026-07-30 15:30
Most Read
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
2026-07-30 10:45
10892
Association of Trade and Commerce Reinforces Commitment to Supporting Singapore Enterprises Through Global Growth at The Entrepreneur Singapore 2026
2026-07-31 21:45
10166
KC Global Media announces new travel series "AXN Ultimate Challenge: Sarawak"
2026-07-30 09:12
9685
Articura Launches a New Chapter for Sovereign Healthcare AI in Indonesia
2026-07-27 19:02
9650